These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7628828)

  • 21. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P; Benrezzak O; Arsenault D; Pheng LH; Blouin A; Cayer J; Beaudoin M; Belleville K; Sirois P; Nantel F; Jeng AY; Battistini B
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional hemodynamic effects of neutral endopeptidase inhibition and angiotensin (AT(1)) receptor antagonism alone or in combination in conscious spontaneously hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Ballard SA; Bennett T
    J Pharmacol Exp Ther; 2006 Oct; 319(1):340-8. PubMed ID: 16825530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats.
    Lemmer B; Witte K; Makabe T; Ganten D; Mattes A
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):311-4. PubMed ID: 7511762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia.
    Amrani FC; Cheaw SL; Chevalier B; Paolaggi F; Jouquey S; Hamon G; Swynghedauw B
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):155-65. PubMed ID: 7511729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
    Fournié-Zaluski MC; Gonzalez W; Turcaud S; Pham I; Roques BP; Michel JB
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4072-6. PubMed ID: 8171037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term cardiac effects of hypotensive agents in normotensive mature rats: comparison of beta-blocking agent and converting enzyme inhibition.
    Azizi M; Levy B; Salzmann JL; Cerol ML; Poitevin P; Ménard J; Michel JB
    J Cardiovasc Pharmacol; 1989 May; 13(5):691-701. PubMed ID: 2472516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamics.
    Varagic J; Susic D; Slama M; Frohlich ED
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):167-74. PubMed ID: 12808490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats.
    Widdop RE; Sampey DB; Jarrott B
    Hypertension; 1999 Oct; 34(4 Pt 2):964-8. PubMed ID: 10523392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of amlodipine and benazeprilat in spontaneously hypertensive rats.
    Bazil MK; Webb RL
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):405-11. PubMed ID: 7681501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of bradykinin by the rat coronary vascular bed.
    Dumoulin MJ; Adam A; Blais C; Lamontagne D
    Cardiovasc Res; 1998 Apr; 38(1):229-36. PubMed ID: 9683926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
    Trippodo NC; Fox M; Natarajan V; Panchal BC; Dorso CR; Asaad MM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):108-16. PubMed ID: 8229737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension.
    Plotnikov MB; Shamanaev AY; Aliev OI; Sidekhmenova AV; Anishchenko AM; Arkhipov AM
    J Am Soc Hypertens; 2017 Nov; 11(11):769-778. PubMed ID: 28989072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.